Ceftazidime & Tazobactam Injection – CYDIM -TZ

Ceftazidime & Tazobactam injection – Dual antibiotic therapy for Resistant Bacterial Infections.

CYDIM -TZ – Ceftazidime-1000 mg + Tazobactam-125mg injection combines the power of Ceftazidime, a third-generation cephalosporin with potent bactericidal activity, and Tazobactam, a beta-lactamase inhibitor that neutralizes resistant bacteria. This synergistic combination disrupts bacterial cell wall synthesis and combats beta-lactamase enzymes, making it highly effective against multidrug-resistant infections. The injection form ensures rapid and targeted treatment for severe and life-threatening diseases.

Recommended by specialists:
✅Pulmonologists: For hospital-acquired pneumonia, ventilator-associated pneumonia, and severe lower respiratory tract infections.
✅Critical Care Specialists: In ICU settings for sepsis, intra-abdominal infections, and post-surgical infections in high-risk patients.
✅General Physician: For complicated urinary tract infections (UTIs), bacteremia, and skin/soft tissue infections in hospitalized patients.

Key benefits Of Ceftazidime & Tazobactam Injection – CYDIM -TZ
✅Broad-Spectrum Efficacy: Effective against gram-negative bacteria, specific gram-positive pathogens, and aerobic organisms, including Pseudomonas aeruginosa.
✅Synergistic Combination: Ceftazidime targets gram-negative infections, while Tazobactam enhances efficacy against resistant bacteria and beta-lactamase-producing strains.
✅Versatile Coverage: Treats a wide range of infections, including CNS, respiratory, urinary, and bone and joint infections.

Indications –
✅Resistant bacterial infections
✅ CNS infections (e.g., meningitis)
✅Urinary tract infections (UTIs)
✅Respiratory tract infections
✅Bone, joint, and soft tissue infections